New research shows small-molecule drugs can precisely control therapeutic genome editing, achieving 85% improved accuracy while reducing off-target effects by 67%. This breakthrough could revolutionize gene therapy safety and effectiveness. β Photo: www.kaboompics.com / Pexels
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.
